SEC 13F Intelligence

Consonance Capital Management LP / VNDA

Consonance Capital Management LP’s Vanda Pharmaceuticals Inc Position

Does Consonance Capital Management LP own Vanda Pharmaceuticals Inc (VNDA)? Not currently — the last reported position was 3.63M shares worth $51M in Q2 2019; the fund’s latest 13F (Q3 2022) no longer reports it.

Position Value
$51M
Q2 2019
Shares
3.63M
% of Portfolio
+3.62%
Quarters Held
2
position exited

Position History VNDA

Reported value by quarter
Q1 ’19: $78MQ1 ’19Q2 ’19: $51MQ2 ’19filingsflow.com
QuarterSharesValue% of Portfolio
Q2 20193.63M$51M+3.62%
Q1 20194.26M$78M+4.95%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Consonance Capital Management LP’s full portfolio or all institutional holders of VNDA.